Treatment of SF126 and SF767 cells with 5-Aza-dC restored LRRC4 expression, which suggests that aberrant hypermethylation of the promoter is directly responsible for transcription inactivation of its expression in glioma cell lines. Here, LRRC4 is linked to glioma.